#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ovarian cancer stage III Vascular calcification Erythema Transplant rejection Liposarcoma Cystic fibrosis Hepato-lenticular degeneration Neuroblastoma recurrent Diffuse large B-cell lymphoma recurrent Glomerulonephritis acute Malignant central nervous system neoplasm Squamous cell carcinoma of head and neck HER2 mutant non-small cell lung cancer Metachromatic leukodystrophy Follicular lymphoma stage I More trials…

    Learn about Rare Diseases

    Propionic acidaemia Mantle cell lymphoma refractory – Basic Information Langerhans’ cell histiocytosis – Basic Information Burkitt’s lymphoma Familial haemophagocytic lymphohistiocytosis – Life with Disease Pelizaeus-Merzbacher disease SAPHO syndrome – Trials in Disease Medulloblastoma recurrent – Diagnostics Angiosarcoma recurrent Chondrosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ZINC GLUCONATE SAR444336 Asfotase Alfa Hydroxocobalamin Seladelpar Fenfluramine Hydrochloride Lenalidomide Ucp4 (-)-PHENSERINE TARTRATE Ademetionine Cilastatin Sodium Dapagliflozin Propanediol Oregovomab Gimeracil Ascorbic Acid Bp SODIUM BENZOATE Hct116-A Olaptesed Pegol Cetirizine Betibeglogene Autotemcel More therapies…

    Learn about Your Condition

    Decreased appetite K-ras gene mutation Peripheral artery restenosis Nasal sinus cancer Binge eating Antisynthetase syndrome Varicella Ocular melanoma Polycystic liver disease Rectal cancer recurrent Lung cancer metastatic Intestinal obstruction Spermatocele Pleural mesothelioma malignant Bone hypertrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Bevacizumab for Patients with Newly Diagnosed IDH Wild-Type, MGMT Unmethylated Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Bevacizumab
    Germany

  • Study on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Meningioma malignant
    Investigated Drugs:
    • Regorafenib
    Italy

  • Study on Bupivacaine Hydrochloride and Sodium Chloride for Recovery After Minimally Invasive Colorectal Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bupivacaine Hydrochloride, Anhydrous
    • Sodium Chloride
    The Netherlands

  • Study of Chemoradiation with Carboplatin and Paclitaxel for Elderly Patients with Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    Investigated Drugs:
    • Carboplatin
    • Paclitaxel
    France

  • Study on the Safety and Effects of Lutetium (177Lu) rhPSMA-10.1 Injection in Men with Advanced Prostate Cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • 177Lu-Rhpsma-10.1
    Belgium Germany The Netherlands

  • Study on the Effects of R3R01 on Reducing Protein in Urine for Patients with Diabetic Kidney Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Pentetic Acid
    • R3R01
    Denmark
Previous Page
1 … 523 524 525 526 527 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!